Cookies on GOV.UK
We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
additional cookies
View cookies
Skip to main content
Services and information
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
Government activity
●
Departments, agencies and public bodies
●
News stories, speeches, letters and notices
●
Detailed guidance, regulations and rules
●
Reports, analysis and official statistics
●
Consultations and strategy
●
Data, Freedom of Information releases and corporate reports
Search
Register to vote
Register by 18 June to vote in the General Election on 4 July.
(一)
Home
(二)
Health and social care
(三)
Public health
(四)
Health protection
(五)
Health surveillance and reporting programmes
Collection
Tuberculosis (TB): diagnosis, screening, management and data
Information on the diagnosis, screening, epidemiology and public health strategy for tuberculosis and other mycobacterial diseases.
From:
UK Health Security Agency
Published
1 June 2014
Last updated
30 November 2023
—
See all updates
Contents
(一)
Diagnosis
(二)
Treatment, management and vaccination
(三)
Epidemiology
(四)
Screening
(五)
NKS-TB treatment and management advice
(六)
National tuberculosis strain typing service
(七)
Strategy
(八)
Mycobacterium bovis (M. bovis)
Tuberculosis (TB) is an infection caused by a bacterium belonging to the Mycobacterium tuberculosis complex, which includes:
●M. tuberculosis
●M. africanum
●M. bovis
●some rare bacteria such as M. microti and M. pinnipedii
TB is a notifiable disease in the UK. Suspected and confirmed diseases must be notified within 3 working days.
For symptoms and general information on tuberculosis, visit NHS.UK.
Diagnosis
Tuberculosis: notifying cases
●
●
Guidance
Tuberculosis reference laboratories
●
●
Guidance
Tuberculosis (TB): direct molecular testing for TB
●
●
Guidance
Tuberculosis (TB): Interferon Gamma Release Assay tests
●
●
Guidance
Tuberculosis (TB): national audit of laboratories
●
●
Guidance
Treatment, management and vaccination
Standard anti-TB treatment consists of a combination of 4 different antibiotics, usually taken daily for a minimum 6-month period. See National Institute for Health and Care Excellence (NICE) guidelines on treatment of TB.
The BCG vaccine is recommended for high risk groups such as healthcare workers and babies at increased risk of exposure to TB infection.
See the chapter about tuberculosis (TB) immunisation in Immunisation against infectious disease: the Green Book.
For further information about BCG vaccine and supporting resources please go to Immunisation
Managing tuberculosis (TB) in prisons
●
●
Guidance
Tuberculosis: the disease, its treatment and prevention
●
●
Promotional material
Tuberculosis by country: rates per 100,000 people
●
●
Research and analysis
Latent TB infection (LTBI): testing and treatment
●
●
Guidance
Latent TB testing and treatment: leaflet
●
●
Promotional material
Epidemiology
UK Health Security Agency runs enhanced tuberculosis surveillance (ETS) for real-time case reporting. ETS also has laboratory data on drug sensitivity, species and strain typing.
Tuberculosis in England: national quarterly reports
●
●
Official Statistics
Reports of cases of TB to UK enhanced tuberculosis surveillance systems
●
●
Official Statistics
Tuberculosis (TB) notifications reported to enhanced TB surveillance systems: UK, 2000 to 2022
●
●
Official Statistics
Tuberculosis in England, 2022 report (data up to end of 2021)
●
●
Research and analysis
Tuberculosis in England, 2021 report (data up to end of 2020)
●
●
Research and analysis
Tuberculosis (TB) in England: ad hoc provisional data
●
●
Research and analysis
Tuberculosis (TB) in England: surveillance data
●
●
Research and analysis
Tuberculosis (TB): annual notification data 1913 onwards
●
●
Research and analysis
Tuberculosis (TB) in the UK: annual report data up to 2013
●
●
Research and analysis
UK tuberculosis (TB) surveillance data up to 2013
●
●
Official Statistics
Tuberculosis (TB): annual update
●
●
Research and analysis
Tuberculosis (TB): regional and devolved administration reports
●
●
Research and analysis
Screening
Tuberculosis screening
●
●
Guidance
Tuberculosis (TB) screening for the UK: leaflet
●
●
Promotional material
Tuberculosis: pre-entry screening in the UK
●
●
Guidance
NKS-TB treatment and management advice
The national knowledge service - tuberculosis (NKS-TB) provides guidance for health professionals who treat and manage TB in patients.
To view patient resources developed by NKS-TB visit
NHS Choices
Tuberculosis (TB) in the workplace
●
●
Guidance
Tuberculosis (TB) and homelessness
●
●
Guidance
Tuberculosis (TB) and substance misuse
●
●
Guidance
Tuberculosis (TB) and asylum seekers
●
●
Guidance
Tuberculosis (TB) and children
●
●
Guidance
Universal HIV testing for TB patients
●
●
Guidance
Tuberculosis and pregnant women
●
●
Guidance
Tuberculosis: information for prison and immigration removal centre staff
●
●
Guidance
Tuberculosis (TB): molecular diagnosis
●
●
Guidance
National tuberculosis strain typing service
The national strain typing service involves prospectively typing TB isolates using 24 loci mycobacterial interspersed repeat units - variable number tandem repeats (MIRU-VNTR). The results of this are used in local or national investigation of suspected TB transmission incidents.
Previous reports and resources were published by Public Health England:
Enhanced TB surveillance strain typing module: user guide
●Tuberculosis (TB) strain typing service: evaluation
●M. tuberculosis strain typing: data production and distribution
●National TB strain typing service: summary report
National TB strain typing service: what we do
●
●
Guidance
National TB strain typing service: factsheet
●
●
Guidance
Mycobacterium tuberculosis whole genome sequencing and cluster investigation
●
●
Guidance
Strategy
Subscribe to the TB Strategy Implementation Update for progress on the TB strategy.
Tuberculosis (TB): collaborative strategy for England
●
●
Policy paper
Tuberculosis (TB): a resource to support TB in low incidence areas
●
●
Guidance
Health matters: reducing the burden of tuberculosis
●
●
Guidance
Tackling TB in inclusion health groups: toolkit for a multi-agency approach
●
●
Guidance
Mycobacterium bovis (M. bovis)
Human cases of tuberculosis caused by Mycobacterium bovis (M. bovis) are rare. These pages present surveillance data on the numbers of human cases of M. bovis and guidance on management of the disease in cattle and other animals to reduce the risk of human infection.
Tuberculosis caused by Mycobacterium bovis: notification data
●
●
Research and analysis
Mycobacterium bovis (M. bovis): enhanced surveillance questionnaire
●
●
Form
Bovine tuberculosis (TB): public health management
●
●
Guidance
Mycobacterium bovis (M. bovis): reducing the risk of human infection
●
●
Guidance
Published 1 June 2014
Last updated 30 November 2023
+ show all updates
(一)
Added 'Tuberculosis (TB) notifications reported to enhanced TB surveillance systems: UK, 2000 to 2022'.
(二)
Added 'Tuberculosis in England, 2022 report (data up to end of 2021)' and 'Reports of cases of TB to UK enhanced tuberculosis surveillance systems, 2000 to 2021'.
(三)
Archived PHE documents.
(四)
Added 'Tuberculosis in England: national quarterly reports'.
(五)
Publication "Tuberculosis (TB): a resource to support TB in low incidence areas" in the 'Strategy' section.
(六)
Added 'National quarterly report of tuberculosis in England: Quarter 4, 2019 provisional data' report.
(七)
Added new page 'Tuberculosis in England: quarterly reports'.
(八)
Added TB annual report for 2018 and the 2018 slide set.
(九)
Added resource for tackling tuberculosis in under-served populations.
(十)
Added guidance for the unlicensed BCG vaccine, in response to a vaccine shortage: training material for healthcare professionals; guide for parents and carers.
(11)
Added existing latent TB testing guidance and patient leaflet in multiple languages to the collection.
(12)
Added treatment and management advice documents from the National Knowledge Service.
(13)
Added publications under 'NKS-TB treatment and management advice'.
(14)
Publishing annual report and statistics covering up to 2014.
(15)
The Tuberculosis in Kent, Surrey and Sussex: annual report has been published.
(16)
The Tuberculosis: notifying cases guidance has been added.
(17)
Updated to include 'Bovine tuberculosis: public health management' guidance.
(18)
2014 annual report added.
(19)
First published.
Contents
●
●
●
●
●
●
●
Is this page useful?
●
Maybe
●
●
Thank you for your feedback
To help us improve GOV.UK, we’d like to know more about your visit today.
Please fill in this survey (opens in a new tab).
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
Support links
●
●
●
●
●
●
●
●